Clinical trials
Hepatorenal Syndrome clinical trials
Below are recruiting hepatorenal syndrome clinical trials, each written for real people, not researchers. We’re tracking 5 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06095440Recruiting
A study on treatment results for hepatorenal syndrome
This study looks back at medical records of people who had hepatorenal syndrome (a type of kidney failure linked to liver disease) while in the hospital. The goal is to understand what treatments were used and how well patients did, which might help guide future care.
Dallas, TexasAges 18–85 - NCT02434445Recruiting
Blood and urine tests to predict kidney failure in cirrhosis
This study checks new blood and urine tests to predict who with advanced liver scarring (cirrhosis) will develop hepatorenal syndrome, a serious kidney problem. The results may help doctors spot risk earlier, especially for people being referred for a liver transplant.
Hong KongAges 18–90 - NCT04446858Recruiting
Ultrasound tests to study kidney failure in liver pressure disease
This trial studies whether special non-invasive ultrasound scans can help predict outcomes in people who have both liver-related high blood pressure in the veins (portal hypertension) and kidney failure. It may help doctors choose better monitoring and treatment for this specific combination of problems.
BonnAges 18–100 - NCT05346393Recruiting
TIPS procedure for kidney failure in people with cirrhosis
This trial studies whether a liver procedure called TIPS can help people with cirrhosis who develop sudden kidney failure (HRS-AKI). It aims to improve kidney function and overall outcomes, but participation depends on several safety checks.
AachenAges 18–80 - NCT06525623Recruiting
Early albumin for kidney injury in cirrhosis
This study tests whether giving a common fluid (albumin) early can help protect the kidneys in people with advanced liver disease who have a sudden kidney injury. It aims to see if this simple treatment can improve recovery and prevent the need for dialysis.
Boston, MassachusettsAges 18 years+
Hear when a new Hepatorenal Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hepatorenal syndrome?
- Yes. Clin2 currently lists 5 recruiting hepatorenal syndrome studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hepatorenal syndrome trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hepatorenal syndrome trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.